1. Home
  2. LFVN vs MSD Comparison

LFVN vs MSD Comparison

Compare LFVN & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFVN
  • MSD
  • Stock Information
  • Founded
  • LFVN N/A
  • MSD 1993
  • Country
  • LFVN United States
  • MSD United States
  • Employees
  • LFVN N/A
  • MSD N/A
  • Industry
  • LFVN Biotechnology: Pharmaceutical Preparations
  • MSD Trusts Except Educational Religious and Charitable
  • Sector
  • LFVN Health Care
  • MSD Finance
  • Exchange
  • LFVN Nasdaq
  • MSD Nasdaq
  • Market Cap
  • LFVN 165.9M
  • MSD 159.3M
  • IPO Year
  • LFVN N/A
  • MSD N/A
  • Fundamental
  • Price
  • LFVN $12.01
  • MSD $7.59
  • Analyst Decision
  • LFVN Strong Buy
  • MSD
  • Analyst Count
  • LFVN 2
  • MSD 0
  • Target Price
  • LFVN $30.50
  • MSD N/A
  • AVG Volume (30 Days)
  • LFVN 180.7K
  • MSD 70.2K
  • Earning Date
  • LFVN 08-27-2025
  • MSD 01-01-0001
  • Dividend Yield
  • LFVN 1.35%
  • MSD 11.26%
  • EPS Growth
  • LFVN 152.87
  • MSD N/A
  • EPS
  • LFVN 0.70
  • MSD N/A
  • Revenue
  • LFVN $222,347,000.00
  • MSD N/A
  • Revenue This Year
  • LFVN $17.36
  • MSD N/A
  • Revenue Next Year
  • LFVN $9.60
  • MSD N/A
  • P/E Ratio
  • LFVN $16.87
  • MSD N/A
  • Revenue Growth
  • LFVN 8.22
  • MSD N/A
  • 52 Week Low
  • LFVN $5.76
  • MSD $6.11
  • 52 Week High
  • LFVN $27.38
  • MSD $7.46
  • Technical
  • Relative Strength Index (RSI)
  • LFVN 40.54
  • MSD 43.03
  • Support Level
  • LFVN $12.94
  • MSD $7.60
  • Resistance Level
  • LFVN $14.62
  • MSD $7.71
  • Average True Range (ATR)
  • LFVN 0.75
  • MSD 0.08
  • MACD
  • LFVN -0.06
  • MSD -0.03
  • Stochastic Oscillator
  • LFVN 16.37
  • MSD 20.59

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

Share on Social Networks: